This PGD template supports the administration of the RSV vaccine to:

• women from 28 weeks of pregnancy
• older adults aged 75 years and above
• residents in care homes for older adults
• individuals aged 65 to 7974 years with either chronic respiratory disease or immunosuppression due to disease or treatment, as outlined in Table 1 of agethe RSV Green Book chapter

in accordance with the national programme as outlined in the RSV letter and the RSV Green Book chapter 27a.

The RSV vaccine PGD version 1.003.0 is valid from 1 September 20242026 to 131 AprilAugust 2027.2029

Practitioners must not use this template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy and procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and summary of product characteristics for the vaccine.